Advance Care Planning in Neurodegenerative Disorders: A Scoping Review
- PMID: 35055625
- PMCID: PMC8775509
- DOI: 10.3390/ijerph19020803
Advance Care Planning in Neurodegenerative Disorders: A Scoping Review
Abstract
Advance care planning (ACP) is increasingly acknowledged as a key step to enable patients to define their goals/preferences for future medical care, together with their carers and health professionals. We aimed to map the evidence on ACP in neurodegenerative disorders. We conducted a scoping review by searching PubMed (inception-December 28, 2020) in addition to trial, review, and dissertation registers. From 9367 records, we included 53 studies, mostly conducted in Europe (45%) and US-Canada (41%), within the last five years. Twenty-six percent of studies were qualitative, followed by observational (21%), reviews (19%), randomized controlled trials (RCTs, 19%), quasi-experimental (11%), and mixed-methods (4%). Two-thirds of studies addressed dementia, followed by amyotrophic lateral sclerosis (13%), and brain tumors (9%). The RCT interventions (all in dementia) consisted of educational programs, facilitated discussions, or videos for patients and/or carers. In conclusion, more research is needed to investigate barriers and facilitators of ACP uptake, as well as to develop/test interventions in almost all the neurodegenerative disorders. A common set of outcome measures targeting each discrete ACP behavior, and validated across the different diseases and cultures is also needed.
Keywords: advance care planning; dementia; end of life care; ethics; nervous system diseases; neurodegenerative disorders; palliative care; review literature; shared decision making.
Conflict of interest statement
A.L. has served as a Biogen, Merck Serono, Novartis, Roche, Sanofi/ Genzyme and Teva Advisory Board Member. She received congress and travel/accommodation expense compensations or speaker honoraria from Biogen, Merck, Mylan, Novartis, Sanofi/Genzyme, Teva and Fondazione Italiana Sclerosi Multipla (FISM). Her institutions received research grants from Novartis. The other authors declare no conflict of interest.
Figures
References
-
- Brazil K., Scott D., Wallace E., Clarke M., Fahey T., Gillespie P., O’Halloran P., Cardwell C., Carter G., McGlade K., et al. Anticipatory care planning intervention for older adults at risk of functional decline: Study protocol for a primary care cluster feasibility randomised trial. Trials. 2020;21:168. doi: 10.1186/s13063-020-4100-2. - DOI - PMC - PubMed
-
- Rietjens J.A.C., Sudore R.L., Connolly M., van Delden J.J., Drickamer M.A., Droger M., van der Heide A., Heyland D.K., Houttekier D., Janssen D.J.A., et al. European Association for Palliative Care. Definition and recommendations for advance care planning: An international consensus supported by the European Association for Palliative Care. Lancet Oncol. 2017;18:e543–e551. doi: 10.1016/S1470-2045(17)30582-X. - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
